alexa Abstract | The Mediterranean Sponge Dysidea avara as a 40 Year Inspiration of Marine Natural Product Chemists
ISSN: 2332-2543

Journal of Biodiversity & Endangered Species
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Mini Review Open Access


Marine sponges have been intensively studied by organic chemists, biologists and pharmacologists during last 60 years, due to great biodiversity of their secondary metabolites. A couple of very promising bioactivities of these compounds have been reported. Indeed, some of these metabolites are considered as the leads for the future drugs targeting tumours, viral and bacterial diseases, malaria and inflammations. Herein we briefly report key bioactivities of avarol, the main secondary metabolite of the marine sponge Dysidea avara (Schmidt, 1862).

To read the full article Peer-reviewed Article PDF image | Peer-reviewed Full Article image

Author(s): Giuseppina Tommonaro, Carmine Iodice, Faten K. AbdEl-Hady, Giulia Guerriero and Boris Pejin


Marine sponges, Dysidea avara, Avarol, Bioactivity, Antimicrobial, Cytotoxic activities, Alzheimer's disease, Antipsoriatic, Marine diversity, Ecology protection

Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version